top of page
We recognize that patient organizations are the primary driver of rare disease research and therapy development, and that the lack of sufficient research funding for these patient organizations is a major hurdle to finding cures for rare diseases. The 40% aims to make large, sustained research funding available for rare disease patient organizations.
Together, we can make it happen!
bottom of page